Press Release on Atmos Biodefense

NOTE: Major changes have taken place within the organization since the publishing of this post.

Biodefense is a specialized semi-independent branch of Atmos’ X Research University (XRU). The core objective of Biodefense is to proactively mitigate the occurrence of severe and potentially fatal illnesses among humans. This encompasses a spectrum of conditions, notably including cancer, diabetes, tuberculosis, heart disease, Alzheimer’s, and more. Our significant research findings are published publicly to facilitate universal advancement, concurrently informing the development of practical applications aimed at benefiting humanity.

A list of some further human illnesses and complications which we aim to solve, are listed below:

  • Myopia
  • Blindness
  • Tooth Decay
  • Blindness
  • Ebola Virus
  • Stroke
  • Hepatitis
  • Schizophrenia
  • Transmissible spongiform encephalopathies
  • Rabies
  • African trypanosomiasis
  • Naegleriasis
  • Granulomatous amoebic encephalitis
  • Primary amoebic meningoencephalitis
  • Smallpox
  • Anthrax
  • Aspergillosis

Biodefense researchers are closely connected with researchers from X Research University, as they are both under the same entity. Researchers of both the Biodefense branch and X Research University would collaborate with other renowned universities and research institutions around the world to make greater progress by sharing data and knowledge, to ultimately benefit the human race.

It’s unclear at this time when Biodefense will begin formal operations in an effort to begin exploring methods to prevent humans from contracting and/or reliably threat these illnesses and health complications. We lack sufficient funding and resources at this time, and other issues prevent us from beginning. We estimate that far more serious and meaningful developments of Biodefense and Atmos as a whole will take place after April, 2025.

The fundamental goal of Atmos Biodefense is to save humanity time, pain, discomfort, and to boost efficiency and productivity, and happiness, by quickly, reliably, and simply treating illnesses or medical complications, and/or preventing humans from contracting such illnesses or complications in the first place.

Biodefense will also work on anti-aging and long-term life preservation technologies and techniques, and more that is to be announced.

Lastly, it is also important to mention that Biodefense’s methods of illness treatment and prevention will undergo extreme safety testing in every aspect. The goal is to help humans, not to harm humans, therefore, it would be a long time before we can be even 70% certain of the absolute safety of any treatment or prevention methods we develop.

You can learn more about Biodefense on its Atmos webpage by clicking here.

We are taking questions at moc.u1719003979somta1719003979@olle1719003979h1719003979